Medicamen Biotech Limited (MEDICAMEQ) reported revenue of ₹47.90 Cr and net profit of ₹1.85 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from Medicamen Biotech Limited’s filed results, 25 filed quarters and 8 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 15, 2026 · audited
| ₹ Cr | Jun2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Sep2021 | Dec2021 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31.1 | 91.5 | 23.5 | 27.8 | 30.8 | 32.9 | 32.5 | 32.6 | 33.1 | 33.5 | 35.6 | 38.7 | 41.9 | 43.5 | 46.5 | 47.3 | 43.0 | 44.7 | 45.1 | 29.6 | 43.0 | 47.2 | 46.9 | 60.6 | 47.9 | +11.3% |
| 26.9 | 79.4 | 21.2 | 24.6 | 26.3 | 28.5 | 26.3 | 26.3 | 27.4 | 27.7 | 29.7 | 32.2 | 35.0 | 38.9 | 41.6 | 41.6 | 39.6 | 39.4 | 38.4 | 31.2 | 38.4 | 42.0 | 42.5 | 55.2 | 43.6 | +13.4% | |
| Operating profit | — | — | — | — | — | — | 6.23 | 6.31 | 5.66 | 5.85 | 5.88 | 6.49 | 6.95 | 4.65 | 4.89 | 5.75 | 3.45 | 5.32 | 6.71 | -1.61 | 4.62 | 5.16 | 4.38 | 5.44 | 4.33 | -6.3% |
| OPM % | — | — | — | — | — | — | 19.1% | 19.3% | 17.1% | 17.4% | 16.5% | 16.8% | 16.6% | 10.7% | 10.5% | 12.2% | 8.0% | 11.9% | 14.9% | -5.4% | 10.7% | 10.9% | 9.3% | 9.0% | 9.0% | -1.7 pp |
| Other income | 0.04 | 0.22 | 1.10 | 0.08 | 0.13 | 0.00 | 0.48 | 0.83 | 0.96 | 0.52 | 0.63 | 0.35 | 0.38 | 0.55 | 0.83 | 0.57 | 0.59 | 0.29 | 0.14 | 5.23 | 0.47 | 0.37 | 0.53 | 1.74 | 0.86 | +83.2% |
| Interest | — | — | — | — | — | — | 0.30 | 0.49 | 0.77 | 0.62 | 0.68 | 0.86 | 0.96 | 0.91 | 0.65 | 1.89 | 0.71 | 1.04 | 0.76 | 0.65 | 1.15 | 0.99 | 0.97 | 0.38 | 0.83 | -28.1% |
| Depreciation | — | — | — | — | — | — | 1.35 | 1.57 | 1.53 | 1.62 | 1.60 | 1.62 | 1.69 | 1.82 | 1.80 | 1.77 | 1.77 | 2.61 | 2.21 | 0.48 | 1.80 | 1.86 | 1.83 | 1.73 | 1.79 | -0.8% |
| Profit before tax | 4.32 | 12.3 | 3.38 | 3.24 | 4.60 | 4.45 | 5.05 | 5.08 | 4.33 | 4.14 | 4.22 | 4.36 | 4.68 | 2.46 | 3.27 | 2.66 | 1.56 | 1.96 | 3.88 | 2.49 | 2.13 | 2.68 | 2.11 | 5.06 | 2.57 | +20.7% |
| Tax % | 24.1% | 31.0% | 26.3% | 30.6% | 29.9% | 32.3% | 16.5% | 25.6% | 17.1% | 13.0% | 10.7% | 13.5% | 15.7% | 40.1% | 38.0% | 23.2% | 48.7% | 53.8% | 24.6% | 25.2% | 24.9% | 21.2% | 22.6% | 12.1% | 28.2% | +3.3 pp |
| Net profit | 3.28 | 8.48 | 2.49 | 2.24 | 3.22 | 3.01 | 4.22 | 3.78 | 3.59 | 3.60 | 3.77 | 3.77 | 3.95 | 1.48 | 2.03 | 2.04 | 0.80 | 0.90 | 2.92 | 1.86 | 1.60 | 2.11 | 1.63 | 4.45 | 1.85 | +15.3% |
| EPS (₹) | — | — | — | — | — | — | 3.46 | 3.09 | 2.94 | 2.85 | 2.98 | 3.03 | 3.12 | 1.17 | 1.60 | 1.61 | 0.63 | 0.71 | 2.30 | 1.47 | 1.18 | 1.56 | 1.21 | 3.28 | 1.36 | +15.3% |
